HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Walmart Program Seeks Greener Beauty, Greater Supplier Transparency

This article was originally published in The Rose Sheet

Executive Summary

Walmart aims to reduce or eliminate high-priority toxins from its beauty offering with a program announced Sept. 12. The Campaign for Safe Cosmetics celebrates the move and calls on Target to implement a similar safe-cosmetics policy in its stores.

You may also be interested in...



Study: Chemical Hazard Assessment Tools Yield Widely Different Results

Retailers and personal-care manufacturers should take context into account when using hazard assessment tools and communicating findings to the consumers they serve – let alone replacing ingredients with "greener" alternatives – as different approaches can generate widely varying outcomes, a new study suggests.

Clean Bill Of Health For BPA In Europe As FDA Examination Continues

EFSA’s conclusion differs from decisions in Canada and the U.S. banning use of the substance as an epoxy resin coating in infant formula packaging. But EFSA lowers its “tolerable daily intake” level for BPA from 50 micrograms to 4 micrograms per kilogram of body weight.

In Brief: CSC For Walgreens Chemicals Policy; NATRUE/IBD Mutual Recognition; More

Walgreens could be the next retailer to adopt a safe chemicals policy for personal-care products carried in its stores if the Campaign for Safe Cosmetics’ latest campaign proves effective. More news in brief.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018725

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel